Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:B6ZGS9 (
Farnesoid X receptor
)
212
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Thrombomodulin (TM) serves as a vasoprotective molecule on the surface of vascular endothelial cells (VECs) to maintain the endothelial microenvironment by suppressing cellular proliferation, adhesion and inflammatory responses.
Farnesoid X receptor
(
FXR
), a nuclear receptor (NR) and originally considered as a bile acid-activated
transcriptional factor
, not only regulates metabolism homeostasis, but also influences cholesterol transport, vascular tension, and inflammation. Recent studies have shown that TM expression is upregulated by several NRs. However, it is unknown whether there is a link between
FXR
and TM. Our studies demonstrated that TM expression and activity were up-regulated by
FXR
activation in VECs. Reporter assays showed that
FXR
activation significantly enhanced the transcriptional activity of human TM gene promoter. Elecrophoretic mobility-shift and chromatin immunoprecipitation assays indicated that
FXR
induced TM expression by binding to a novel
FXR
-responsive element (FXRE), an inverted repeat DNA motif, IR8 (-503 AGGTCCtcccaaagTGCCCT-484) in the promoter region of TM gene. These results suggest that
FXR
may serve as a novel molecular target for manipulating TM expression and activity in VECs, which may be helpful for designing the therapeutic strategies to the treatment of associated diseases by targeting
FXR
/TM pathway.
...
PMID:Upregulation of thrombomodulin expression by activation of farnesoid X receptor in vascular endothelial cells. 2404 25
Farnesoid X receptor
(
FXR
) is a ligand-activated
transcriptional factor
belonged to the superfamily of nuclear receptors. In the past decades,
FXR
has been found with important roles in the regulation of metabolic homeostasis of bile acids, cholesterol, lipids and carbohydrates. Recent studies further demonstrate the potential protective effect of
FXR
against metabolic diseases, such as hyperglycemia and hyperlipidemia, as well as inflammatory bowel diseases (IBD). In addition,
FXR
plays an essential role in liver regeneration, tumor cell proliferation and apoptosis. However, the role of
FXR
in the development of tumor is still obscure and even with discrepancy. This article reviews the function of
FXR
in metabolic regulation and recent progress in basic, clinical and pharmacological researches related to tumor cell proliferation involving
FXR
.
...
PMID:[Progress in the role of farnesoid X receptor in metabolic regulation and tumor cell proliferation]. 2477 17